Skip to main content

Maribavir Dosage

Medically reviewed by Drugs.com. Last updated on Mar 20, 2024.

Applies to the following strengths: 200 mg

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for CMV Infection

400 mg orally twice a day

Use: For the treatment of patients with posttransplant CMV infection/disease refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir, or foscarnet

Usual Pediatric Dose for CMV Infection

12 years or older:


Use: For the treatment of patients with posttransplant CMV infection/disease refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir, or foscarnet

Renal Dose Adjustments

Mild, moderate, or severe renal dysfunction: No adjustment recommended
ESRD: Data not available

Liver Dose Adjustments

Mild (Child-Pugh A) or moderate (Child-Pugh B) liver dysfunction: No adjustment recommended
Severe liver dysfunction: Data not available

Dose Adjustments

Coadministration with carbamazepine: Maribavir 800 mg orally twice a day
Coadministration with phenytoin or phenobarbital: Maribavir 1200 mg orally twice a day

Precautions

CONTRAINDICATIONS: None

Safety and efficacy have not been established in patients younger than 12 years.

Consult WARNINGS section for additional precautions.

Dialysis

ESRD on dialysis: Data not available

Comments:

Other Comments

Administration advice:


Administration of Dispersed Tablets or Crushed Tablets by Mouth:

Administration of Dispersed Tablets through a Nasogastric (NG) or Orogastric (OG) Tube:

Storage requirements:

Reconstitution/preparation techniques:

Monitoring:

Patient advice:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.